Action Tetra Bio Pharma - TBP

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

0,025

Prix Achat

0,01

Prix Vente

0,025

Volume échangé

0,00 Fourchette du Jour 0,00

0,025 Plage de 52 semaines 0,025

Clôture Veille

0,025

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Tetra Bio-Pharma Announces Listing to OTCPink Market

Tetra Bio-Pharma Announces Listing to OTCPink Market PR Newswire MONTREAL, Feb. 10, 2023 MONTREAL, Feb. 10...

REDUVO™ Marketing Approval on the Right Path

REDUVO™ Marketing Approval on the Right Path PR Newswire MONTREAL, Dec. 22, 2022 Second Clarifax...

Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir

Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir PR...

Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003

Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003 PR Newswire MONTREAL...

Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug Submission

Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug Submission PR Newswire MONTREAL, Nov. 18, 2022...

Tetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue Ocean

Tetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue Ocean PR Newswire OTTAWA, ON, Oct...

Tetra and Prepaire Jointly Apply to BARDA for Funding

Tetra and Prepaire Jointly Apply to BARDA for Funding PR Newswire OTTAWA, ON, Oct. 11, 2022 Companies jointly...

Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue Ocean

Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue Ocean PR...

Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 Patients

Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 Patients PR...

Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue Ocean

Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue Ocean PR Newswire OTTAWA, ON, Aug. 11, 2022...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0.025	0.025	0.025	0	0	CS
4	0	0	0.025	0.025	0.025	0	0	CS
12	0	0	0.025	0.025	0.025	0	0	CS
26	0	0	0.025	0.025	0.025	0	0	CS
52	0	0	0.025	0.025	0.025	0	0	CS
156	-0.045	-64.2857142857	0.07	0.09	0.015	217393	0.03712545	CS
260	-0.205	-89.1304347826	0.23	0.53	0.015	585167	0.20799004	CS

TBP - Frequently Asked Questions (FAQ)

What is the current Tetra Bio Pharma share price?

The current share price of Tetra Bio Pharma is $ 0,025

What is the 1 year trading range for Tetra Bio Pharma share price?

Tetra Bio Pharma has traded in the range of $ 0,025 to $ 0,025 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
134AUPraise Inc	0,00 (0,00%)	0
1332Nissui Corporation	0,00 (0,00%)	0
132AIN Holdings Co Ltd	0,00 (0,00%)	0
131ACCN Group Corp	0,00 (0,00%)	0
130AVeritas In Silico Inc	0,00 (0,00%)	0
134AUPraise Inc	0,00 (0,00%)	0
1332Nissui Corporation	0,00 (0,00%)	0
132AIN Holdings Co Ltd	0,00 (0,00%)	0
131ACCN Group Corp	0,00 (0,00%)	0
130AVeritas In Silico Inc	0,00 (0,00%)	0
134AUPraise Inc	0,00 (0,00%)	0
1332Nissui Corporation	0,00 (0,00%)	0
132AIN Holdings Co Ltd	0,00 (0,00%)	0
131ACCN Group Corp	0,00 (0,00%)	0
130AVeritas In Silico Inc	0,00 (0,00%)	0

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Tetra Bio Pharma Inc (TBP)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

TBP Dernières nouvelles

Tetra Bio-Pharma Announces Listing to OTCPink Market

REDUVO™ Marketing Approval on the Right Path

Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir

Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003

Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug Submission

Tetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue Ocean

Tetra and Prepaire Jointly Apply to BARDA for Funding

Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue Ocean

Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 Patients

Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue Ocean

TBP - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Tetra Bio Pharma Inc (TBP) Cours

Tetra Bio Pharma Inc (TBP)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

TBP Dernières nouvelles

Tetra Bio-Pharma Announces Listing to OTCPink Market

REDUVO™ Marketing Approval on the Right Path

Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir

Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003

Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug Submission

Tetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue Ocean

Tetra and Prepaire Jointly Apply to BARDA for Funding

Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue Ocean

Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 Patients

Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue Ocean

TBP - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités